Establishment of a model to examine the early events involved in the development of virus-induced demyelinating lesions

Kristen M. Drescher, Steven M Tracy

Research output: Chapter in Book/Report/Conference proceedingChapter

1 Citation (Scopus)

Abstract

The ability to study the immediate, early events in the demyelinating process has been difficult on account of the lack of model systems that address this phase of lesion development. The vast majority of animal models used to study multiple sclerosis (MS) focuses on the later events of myelin destruction. To address this deficiency, we have modified the currently used Theiler's murine encephalomyelitis virus (TMEV)-induced model of demyelination to precisely identify the area where virus-induced demyelination first occurs. Following surgical exposure of the spinal cord, we directly injected TMEV into the spinal cord of female SJL/J mice. Characterization of the events in the spinal cord in the days following injection of virus support the use of this model to dissect the pathways triggered in the host in the early phases of demyelination. A complete understanding of the genesis of the sclerotic plaque may provide insights into enhanced treatment for patients with central nervous system (CNS) demyelination.

Original languageEnglish (US)
Title of host publicationHow Do We Best Employ Animal Models for Type 1 Diabetesand Multiple Sclerosis
PublisherBlackwell Publishing Inc.
Pages152-156
Number of pages5
ISBN (Print)1573316784, 9781573316781
DOIs
StatePublished - Jan 1 2007

Publication series

NameAnnals of the New York Academy of Sciences
Volume1103
ISSN (Print)0077-8923
ISSN (Electronic)1749-6632

Fingerprint

Demyelinating Diseases
Viruses
Theilovirus
Spinal Cord
Neurology
Myelin Sheath
Multiple Sclerosis
Animals
Central Nervous System
Animal Models
Injections
Therapeutics

Keywords

  • Demyelination
  • Multiple sclerosis
  • Theiler's murine encephalomyelitis virus
  • Virus-induced demyelination

ASJC Scopus subject areas

  • Neuroscience(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • History and Philosophy of Science

Cite this

Drescher, K. M., & Tracy, S. M. (2007). Establishment of a model to examine the early events involved in the development of virus-induced demyelinating lesions. In How Do We Best Employ Animal Models for Type 1 Diabetesand Multiple Sclerosis (pp. 152-156). (Annals of the New York Academy of Sciences; Vol. 1103). Blackwell Publishing Inc.. https://doi.org/10.1196/annals.1394.010

Establishment of a model to examine the early events involved in the development of virus-induced demyelinating lesions. / Drescher, Kristen M.; Tracy, Steven M.

How Do We Best Employ Animal Models for Type 1 Diabetesand Multiple Sclerosis. Blackwell Publishing Inc., 2007. p. 152-156 (Annals of the New York Academy of Sciences; Vol. 1103).

Research output: Chapter in Book/Report/Conference proceedingChapter

Drescher, KM & Tracy, SM 2007, Establishment of a model to examine the early events involved in the development of virus-induced demyelinating lesions. in How Do We Best Employ Animal Models for Type 1 Diabetesand Multiple Sclerosis. Annals of the New York Academy of Sciences, vol. 1103, Blackwell Publishing Inc., pp. 152-156. https://doi.org/10.1196/annals.1394.010
Drescher KM, Tracy SM. Establishment of a model to examine the early events involved in the development of virus-induced demyelinating lesions. In How Do We Best Employ Animal Models for Type 1 Diabetesand Multiple Sclerosis. Blackwell Publishing Inc. 2007. p. 152-156. (Annals of the New York Academy of Sciences). https://doi.org/10.1196/annals.1394.010
Drescher, Kristen M. ; Tracy, Steven M. / Establishment of a model to examine the early events involved in the development of virus-induced demyelinating lesions. How Do We Best Employ Animal Models for Type 1 Diabetesand Multiple Sclerosis. Blackwell Publishing Inc., 2007. pp. 152-156 (Annals of the New York Academy of Sciences).
@inbook{83d5b6ee4fbe436f9aeb79cfc9a00a43,
title = "Establishment of a model to examine the early events involved in the development of virus-induced demyelinating lesions",
abstract = "The ability to study the immediate, early events in the demyelinating process has been difficult on account of the lack of model systems that address this phase of lesion development. The vast majority of animal models used to study multiple sclerosis (MS) focuses on the later events of myelin destruction. To address this deficiency, we have modified the currently used Theiler's murine encephalomyelitis virus (TMEV)-induced model of demyelination to precisely identify the area where virus-induced demyelination first occurs. Following surgical exposure of the spinal cord, we directly injected TMEV into the spinal cord of female SJL/J mice. Characterization of the events in the spinal cord in the days following injection of virus support the use of this model to dissect the pathways triggered in the host in the early phases of demyelination. A complete understanding of the genesis of the sclerotic plaque may provide insights into enhanced treatment for patients with central nervous system (CNS) demyelination.",
keywords = "Demyelination, Multiple sclerosis, Theiler's murine encephalomyelitis virus, Virus-induced demyelination",
author = "Drescher, {Kristen M.} and Tracy, {Steven M}",
year = "2007",
month = "1",
day = "1",
doi = "10.1196/annals.1394.010",
language = "English (US)",
isbn = "1573316784",
series = "Annals of the New York Academy of Sciences",
publisher = "Blackwell Publishing Inc.",
pages = "152--156",
booktitle = "How Do We Best Employ Animal Models for Type 1 Diabetesand Multiple Sclerosis",

}

TY - CHAP

T1 - Establishment of a model to examine the early events involved in the development of virus-induced demyelinating lesions

AU - Drescher, Kristen M.

AU - Tracy, Steven M

PY - 2007/1/1

Y1 - 2007/1/1

N2 - The ability to study the immediate, early events in the demyelinating process has been difficult on account of the lack of model systems that address this phase of lesion development. The vast majority of animal models used to study multiple sclerosis (MS) focuses on the later events of myelin destruction. To address this deficiency, we have modified the currently used Theiler's murine encephalomyelitis virus (TMEV)-induced model of demyelination to precisely identify the area where virus-induced demyelination first occurs. Following surgical exposure of the spinal cord, we directly injected TMEV into the spinal cord of female SJL/J mice. Characterization of the events in the spinal cord in the days following injection of virus support the use of this model to dissect the pathways triggered in the host in the early phases of demyelination. A complete understanding of the genesis of the sclerotic plaque may provide insights into enhanced treatment for patients with central nervous system (CNS) demyelination.

AB - The ability to study the immediate, early events in the demyelinating process has been difficult on account of the lack of model systems that address this phase of lesion development. The vast majority of animal models used to study multiple sclerosis (MS) focuses on the later events of myelin destruction. To address this deficiency, we have modified the currently used Theiler's murine encephalomyelitis virus (TMEV)-induced model of demyelination to precisely identify the area where virus-induced demyelination first occurs. Following surgical exposure of the spinal cord, we directly injected TMEV into the spinal cord of female SJL/J mice. Characterization of the events in the spinal cord in the days following injection of virus support the use of this model to dissect the pathways triggered in the host in the early phases of demyelination. A complete understanding of the genesis of the sclerotic plaque may provide insights into enhanced treatment for patients with central nervous system (CNS) demyelination.

KW - Demyelination

KW - Multiple sclerosis

KW - Theiler's murine encephalomyelitis virus

KW - Virus-induced demyelination

UR - http://www.scopus.com/inward/record.url?scp=34249025159&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34249025159&partnerID=8YFLogxK

U2 - 10.1196/annals.1394.010

DO - 10.1196/annals.1394.010

M3 - Chapter

SN - 1573316784

SN - 9781573316781

T3 - Annals of the New York Academy of Sciences

SP - 152

EP - 156

BT - How Do We Best Employ Animal Models for Type 1 Diabetesand Multiple Sclerosis

PB - Blackwell Publishing Inc.

ER -